Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia.

Autor: Lyski ZL; Department of Molecular Microbiology and Immunology and., Kim MS; Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Xthona Lee D; Department of Molecular Microbiology and Immunology and., Raué HP; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR., Raghunathan V; Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Griffin J; Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Ryan D; Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Brunton AE; Oregon Health & Science University-Portland State University School of Public Health, Portland, OR; and., Curlin ME; Division of Infectious Diseases, Department of Medicine, Oregon Health & Science University, Portland, OR., Slifka MK; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR., Messer WB; Department of Molecular Microbiology and Immunology and.; Oregon Health & Science University-Portland State University School of Public Health, Portland, OR; and.; Division of Infectious Diseases, Department of Medicine, Oregon Health & Science University, Portland, OR., Spurgeon SE; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.
Jazyk: angličtina
Zdroj: Blood advances [Blood Adv] 2022 Feb 22; Vol. 6 (4), pp. 1207-1211.
DOI: 10.1182/bloodadvances.2021006633
Databáze: MEDLINE